{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:51Z","timestamp":1790916831481,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":196,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101331","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:50:01Z","timestamp":1784613001000},"page":"101331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pinkbar elevation in colon cancer patients and the therapeutic effects of hAMSCs secretome through AKT\/mTOR and Wnt3a\/\u03b2-catenin signaling pathways in HT-29 colon cancer cells"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0300-7665","authenticated-orcid":false,"given":"Fatemeh","family":"Safari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danial","family":"Hassas Khodravesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Shafiee Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laleh","family":"Mirzanejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ctarc.2026.101331_bib0001","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ctarc.2026.101331_bib0002","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101331_bib0003","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ctarc.2026.101331_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102924","article-title":"Post-progression treatment options after CDK4\/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer","volume":"135","author":"Sahin","year":"2025","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ctarc.2026.101331_bib0005","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.2147\/DDDT.S560518","article-title":"Infusion-related reactions among cancer patients receiving immune checkpoint inhibitors: the ARON-MOUSEION-013 systematic review and meta-analysis","volume":"19","author":"Vitale","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"issue":"43","key":"10.1016\/j.ctarc.2026.101331_bib0006","doi-asserted-by":"crossref","first-page":"75756","DOI":"10.18632\/oncotarget.20798","article-title":"Stem cells in cancer therapy: opportunities and challenges","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctarc.2026.101331_bib0007","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2015.14229","article-title":"Mesenchymal stem cells: myths and reality","volume":"145","author":"Sarukhan","year":"2015","journal-title":"Swiss. Med. Wkly."},{"issue":"Pt 1","key":"10.1016\/j.ctarc.2026.101331_bib0008","article-title":"Exploring the dichotomy of the mesenchymal stem cell secretome: implications for tumor modulation via cell-signaling pathways","volume":"143","author":"Rasouli","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ctarc.2026.101331_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2026.1729022","article-title":"Cell secretome as a potential anticancer therapeutic agent: composition, mechanisms, preclinical evidence, and translational challenges","volume":"16","author":"Alrushaid","year":"2026","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101331_bib0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/sctm.18-0117","article-title":"Mesenchymal stem cell administration attenuates colon cancer progression by modulating the immune component within the colorectal tumor microenvironment","volume":"8","author":"Francois","year":"2019","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101331_bib0011","first-page":"31","article-title":"Wharton's jelly mesenchymal stem cell-derived conditioned media inhibits colon cancer cells via activating AMPK\/mTOR-mediated autophagy","volume":"15","author":"Dayer","year":"2026","journal-title":"Mol. Biol. Res. Commun."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101331_bib0012","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/membranes2010091","article-title":"The bar domain superfamily proteins from subcellular structures to human diseases","volume":"2","author":"Safari","year":"2012","journal-title":"Membranes. (Basel)"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101331_bib0013","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/nsmb.2079","article-title":"Pinkbar is an epithelial-specific BAR domain protein that generates planar membrane structures","volume":"18","author":"Pyk\u00e4l\u00e4inen","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ctarc.2026.101331_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110414","article-title":"BAIAP2L2 promotes the progression of gastric cancer via AKT\/mTOR and Wnt3a\/\u03b2-catenin signaling pathways","volume":"129","author":"Liu","year":"2020","journal-title":"Biomed. PharmacOther"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101331_bib0015","first-page":"1304","article-title":"BAI1associated protein 2like 2 is a potential biomarker in lung cancer","volume":"41","author":"Xu","year":"2019","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101331_bib0016","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000520370","article-title":"Downregulation of pinkbar\/pAKT and MMP2\/MMP9 expression in MDA-MB-231 breast cancer cells as potential targets in cancer therapy by hAMSCs secretome","volume":"212","author":"Shakery","year":"2023","journal-title":"Cells Tissues. Organs"},{"key":"10.1016\/j.ctarc.2026.101331_bib0017","article-title":"Evaluating the in vitro therapeutic effects of human amniotic mesenchymal stromal cells on MiaPaca2 pancreatic cancer cells using 2D and 3D cell culture model","volume":"68","author":"Rahmani","year":"2020","journal-title":"Tissue Cell"},{"key":"10.1016\/j.ctarc.2026.101331_bib0018","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/nrd1902","article-title":"Exploiting the PI3K\/AKT pathway for cancer drug discovery","volume":"4","author":"Hennessy","year":"2005","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.ctarc.2026.101331_bib0019","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","article-title":"PI (3) K and mTOR signalling controls tumour cell growth","volume":"441","author":"Shaw","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2026.101331_bib0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12032-022-01649-4","article-title":"The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1\/Stat3 signaling","volume":"39","author":"Safari","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ctarc.2026.101331_bib0021","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13046-014-0107-4","article-title":"Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression","volume":"33","author":"Qi","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101331_bib0022","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s40880-015-0052-4","article-title":"Wnt3a: functions and implications in cancer","volume":"34","author":"He","year":"2015","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101331_bib0023","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mcn.2013.01.001","article-title":"Wnt3a mediated activation of Wnt\/beta-catenin signaling promotes tumor progression in glioblastoma","volume":"54","author":"Kaur","year":"2013","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.ctarc.2026.101331_bib0024","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1007\/s13277-015-4413-z","article-title":"Abnormality of Wnt3a expression as novel specific biomarker for diagnosis and differentiation of hepatocellular carcinoma","volume":"37","author":"Pan","year":"2016","journal-title":"Tumour. Biol."},{"issue":"19","key":"10.1016\/j.ctarc.2026.101331_bib0025","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.7150\/jca.35009","article-title":"Wnt3a protein overexpression predicts worse overall survival in laryngeal squamous cell carcinoma","volume":"10","author":"Zhang","year":"2019","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101331_bib0026","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12013-022-01066-4","article-title":"The antitumor activity of hAMSCs secretome in HT-29 colon cancer cells through downregulation of EGFR\/c-Src\/IRTKS expression and p38\/ERK1\/2 phosphorylation","volume":"80","author":"Ebadi Zavieh","year":"2022","journal-title":"Cell Biochem. Biophys."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101331_bib0027","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/cbf.3654","article-title":"Evaluating the effect of secretome of human amniotic mesenchymal stromal cells on apoptosis induction and epithelial-mesenchymal transition inhibition in LNCaP prostate cancer cells based on 2D and 3D cell culture models","volume":"39","author":"Safari","year":"2021","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.ctarc.2026.101331_bib0028","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.biologicals.2022.02.001","article-title":"Potential therapeutic effects of hAMSCs secretome on Panc1 pancreatic cancer cells through downregulation of SgK269, E-cadherin, vimentin, and snail expression","volume":"76","author":"Alidoust Saharkhiz Lahiji","year":"2022","journal-title":"Biologicals"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101331_bib0029","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s12094-022-03067-4","article-title":"Therapeutic effects of hAMSCs secretome on proliferation of MDA-MB-231 breast cancer cells by the cell cycle arrest in G1\/S phase","volume":"25","author":"Rahimi Lifshagerd","year":"2023","journal-title":"Clin Transl Oncol."},{"key":"10.1016\/j.ctarc.2026.101331_bib0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.20892\/j.issn.2095-3941.2016.0033","article-title":"Mesenchymal stromal cells\u2019 role in tumor microenvironment: involvement of signaling pathways","volume":"14","author":"Nwabo Kamdje","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.ctarc.2026.101331_bib0031","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/onc.2012.458","article-title":"Mesenchymal stem cells promote growth and angiogenesis of tumors in mice","volume":"32","author":"Huang","year":"2013","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101331_bib0032","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2009.04.013","article-title":"Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion","volume":"284","author":"Pinilla","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ctarc.2026.101331_bib0033","first-page":"95","article-title":"Potential of mesenchymal stem cell based application in cancer","volume":"9","author":"Ramdasi","year":"2015","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"key":"10.1016\/j.ctarc.2026.101331_bib0034","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/1078-0432.CCR-09-1938","article-title":"Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis","volume":"15","author":"Chanda","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101331_bib0035","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1182\/blood-2008-09-176198","article-title":"Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells","volume":"113","author":"Otsu","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101331_bib0036","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1016\/j.febslet.2011.08.005","article-title":"Src-stimulated IRTKS phosphorylation enhances cell migration","volume":"585","author":"Chen","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ctarc.2026.101331_bib0037","doi-asserted-by":"crossref","DOI":"10.1007\/s40883-024-00349-x","article-title":"IRTKS elevation in patients with colon cancer and the curative influences of Hamsc secretome on Polarity and invasion of HT \u201329 colon cancer cells","author":"Khodabandeh","year":"2024","journal-title":"Regen. Eng. Transl. Med."},{"key":"10.1016\/j.ctarc.2026.101331_bib0038","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12247-025-10289-w","article-title":"Elevation of MIM (missing in metastasis) expression in breast cancer cells (MDA-MB-231) under treatment with stem cell secretome","volume":"21","author":"Mojallal","year":"2026","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ctarc.2026.101331_bib0039","article-title":"The elevation of IRSp53 expressing level in colon cancer specimens and the secretome of hAMSCs\u2019 therapeutic impacts on tumor growth promotion via inhibiting of EGFR\/c-Src\/IRSp53\/p-AKT\/p-Stat3\/cyclin D1 signaling cascade in HT-29 colon cancerous cell line","volume":"2025","author":"Alavi","year":"2025","journal-title":"Stem Cell Int."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246829422600242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:01:05Z","timestamp":1790913665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246829422600242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":39,"alternative-id":["S246829422600242X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101331","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pinkbar elevation in colon cancer patients and the therapeutic effects of hAMSCs secretome through AKT\/mTOR and Wnt3a\/\u03b2-catenin signaling pathways in HT-29 colon cancer cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101331","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101331"}}